Amendment in Export Policy of Enoxaparin (formulation and API) and Intra-Venous Immunoglobulin (IVIG) (formulation and API) - 50/2015-2020 - Foreign Trade Policy

Government of India Ministry of Commerce Industry Department of Commerce Directorate General of Foreign Trade Notification No. 50/2015-2020 New Delhi, Dated: 10th January, 2022 Subject: - Amendment in Export Policy of Enoxaparin (formulation and API) and Intra-Venous Immunoglobulin (IVIG) (formulation and API) - regarding S.O. 93 (E) - In exercise of powers conferred by Section 3 read with Section 5 of the Foreign Trade (Development Regulation) Act, 1992 (No. 22 of 1992) , as amended, read with Para 1.02 and 2.01 of the Foreign Trade Policy. 2015-20 . the Central Government hereby makes the following amendment in Chapter 29 and 30 of Schedule 2 of the ITCHS Export policy 2018 related to export of Enoxaparin and Intra-Venous Immunoglobulin (IVIG): S.No ITC HS Codes Description Present Policy Revised Policy 207 AE Ex2942 Ex3001 Ex3002 Enoxaparin (Formulation and API) Free Restricted 207 AF Ex3002 Intra-Venous Immunoglobulin (IVIG) (Formulation and API) Free Restricted 2. Effect of this Notification: The export of Enoxaparin (Formulation and API) and Intra-Venous Immunoglobulin (IVIG) (Formulation and API) falling under the ITC (HS) Codes specified above or falling under any other HS Code has been put under restricted category, with immediate effect. Amit Yadav Director General of Foreign Trade Ex-Officio Additional Secretary, Government of India [Issued from File No. 01/91/180/021/AM22/EC/E-30431]